Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Carcinoma, Renal Cell × Watchful Waiting × Clear all

Status

Completed 2 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 7 Breast Neoplasms 3 Thyroid Neoplasms 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia 2 Glioma 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Brain Neoplasms 2 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Urinary Bladder Neoplasms 1 Thyroid Nodule 1 Thrombocythemia, Essential 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Retinoblastoma 1 Primary Myelofibrosis 1 Precancerous Conditions 1 Polycythemia Vera 1 Pleuropulmonary blastoma 1 Pinealoma 1 Papillary Thyroid Microcarcinoma 1

Interventions

Nivolumab 28 pembrolizumab 24 cabozantinib 23 Ipilimumab 17 Magnetic Resonance Spectroscopy 14 Specimen Handling 13 Axitinib 11 lenvatinib 9 Radiosurgery 8 belzutifan 6 atezolizumab 6 CTLA-4 Antigen 6 Biopsy 6 cemiplimab 5 Radiotherapy 5 Blood Specimen Collection 5 Bevacizumab 5 Standard of Care 4 Everolimus 4 toripalimab 3 avelumab 3 aldesleukin 3 X-Rays 3 Sunitinib 3 Paclitaxel 3 zimberelimab 2 trastuzumab deruxtecan 2 tivozanib 2 pazopanib 2 palbociclib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06336187 2024-04-10

EASE

Azienda Ospedaliero Universitaria Maggiore della Carita

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡